Tag Archives: analyst

J&J analyst day tries to steer focus to drug business as talc baby powder comes under fire

Alex Gorsky, CEO of Johnson & Johnson Adam Jeffery | CNBC Johnson & Johnson‘s pharmaceutical business will take the spotlight Wednesday at its annual meeting with analysts as the company tries to allay investors’ concerns over its talc-based baby powder. The New Brunswick, New Jersey, based health-care conglomerate makes a wide range of products, including… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »